randomized phase III trial (SCIENCE): Comparing chemotherapy plus sintilimab and chemoradiotherapy plus sintilimab versus chemoradiotherapy for neoadjuvant treatment in resectable locally advanced ...

Characterization of the real-world first line (1L) use of single dose tremelimumab regular interval durvalumab (STRIDE), for treatment of unresectable hepatocellular carcinoma (uHCC), using two ...

6. Protein energy malnutrition (PEM): Inadequate intake of protein and calories leads to stunted growth, weakened immune function, and increased susceptibility to infections. READ ALSO ...